Skip to content

A Study on the Characteristics and Diagnosis and Treatment Pathways of the Beneficial Population of Colorectal Cancer with the Equal Emphasis on Traditional Chinese and Western Medicine Scheme

A Study on the Characteristics and Diagnosis and Treatment Pathways of the Beneficial Population of Colorectal Cancer with the Equal Emphasis on Traditional Chinese and Western Medicine Scheme

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081697
Enrollment
Unknown
Registered
2024-03-08
Start date
2022-09-02
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Retrospective research group:Traditional Chinese Medicine Syndrome Differentiation and Treatment Decoction (can be taken with or without Western medicine)
Prospective research group:Traditional Chinese Medicine Syndrome Differentiation and Treatment Decoction (can be taken with or without Western medicine)

Sponsors

Xiyuan, Chinese Academy of Traditional Chinese Medicine Hospital Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Retrospective inclusion criteria ? Pathologically diagnosed as colorectal cancer; ? Patients who visited Xiyuan Hospital from January 1, 2017 to December 31, 2021 ? Age>18 years old, regardless of gender; ? Previously received continuous traditional Chinese medicine treatment for more than 3 months Prospective inclusion criteria ? Pathologically diagnosed as colorectal cancer; ? From January 1, 2022 to December 31, 2023, at Xiyuan Hospital of the Chinese Academy of Traditional Chinese Medicine and Peking University Cancer Hospital ? Age>18 years old, regardless of gender;

Exclusion criteria

Exclusion criteria: Retrospective exclusion criteria ? Previous or combined history of two or more incurable malignant tumors; ? Cases that cannot be traced or tracked through outpatient or telephone follow-up, resulting in severe information loss and affecting the final analysis results; Prospective exclusion criteria ? Previous or combined history of two or more incurable malignant tumors: ? Cases that cannot be followed up through outpatient or telephone means, resulting in severe lack of information and affecting the final analysis results ? The researcher believes that other situations are not suitable for participating in this clinical study.

Design outcomes

Primary

MeasureTime frame
Survival period;tongue and pulse;

Secondary

MeasureTime frame
age at diagnosis;Time at diagnosis;Pathogenic site;Transfer site;Karnofsky score;Traditional Chinese Medicine Intervention Time;Total survival refers to the time from receiving treatment to patient death or the last follow-up time;Progressive survival refers to the time from receiving treatment to disease progression or death from any cause;

Countries

China

Contacts

Public ContactYang Yufei

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine

yyf93@vip.sina.com+86 137 0136 6913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026